Trevena, Inc. Gains 53.73%

Tue, Sep 10, 2024 at 05:30 PM

Trevena, Inc. (TRVN:NASDAQ) shot up at $7.84, a gain of 53.7%. On Mon, Sep 09, 2024, TRVN:NASDAQ touched a New 2-Week High of $5.1. The stock got featured on our News Catalysts scanner on Sat, Sep 07, 2024 at 12:56 AM in the 'MISCELLANEOUS' category. From Mon, Aug 26, 2024, the stock recorded 55.56% Up Days and 60.00% Green Days

About Trevena, Inc. (TRVN:NASDAQ)

Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

Top 10 Gainers:

Hempacco Co. Inc. (HPCO:NASDAQ), 1342.86%
Oruka Therapeutics, Inc. (ABIO:NASDAQ), 1052%
Quhuo Limited (QH:NASDAQ), 306.6%
iLearningEngines Holdings Inc Cl A (AILE:NASDAQ), 115.11%
BIO-key International, Inc. (BKYI:NASDAQ), 92.31%
Trevena, Inc. (TRVN:NASDAQ), 53.73%
FibroBiologics Inc. (FBLG:NASDAQ), 49.62%
SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 47.53%
PAVmed Inc. (PAVM:NASDAQ), 43.7%
LightInTheBox Holding Co., Ltd. (LITB:NYSE), 41.18%